{"id":"W2954966588","doi":"10.1200/jco.2019.37.15_suppl.8018","title":"Patient-reported outcomes (PROs) with ibrutinib-rituximab in Waldenström macroglobulinemia (WM): Results from iNNOVATE.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre; Royal Victoria Regional Health Centre; Ottawa Hospital; Royal Victoria Hospital; University of Ottawa","funders":"","keywords":"Medicine; Rituximab; Ibrutinib; Anemia; Internal medicine; Placebo; Visual analogue scale; Waldenstrom macroglobulinemia; Quality of life (healthcare); Refractory (planetary science); Randomized controlled trial; Gastroenterology; Surgery; Lymphoma; Leukemia; Chronic lymphocytic leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003957574,0.0002792393,0.002839473,0.0003085303,0.00002592663,0.00002112397,0.0003267976,0.0007461825,0.0003560889],"category_scores_gemma":[0.01006885,0.0001747517,0.0003953236,0.000566496,0.0003263969,0.0001499901,0.0001866389,0.00238132,0.0002136967],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.004159244,"about_ca_system_score_gemma":0.02406804,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007621418,"about_ca_topic_score_gemma":0.0002225547,"domain_scores_codex":[0.9915072,0.0004338961,0.005727428,0.0005200655,0.001213778,0.0005976021],"domain_scores_gemma":[0.9899369,0.004748183,0.003155814,0.0007128445,0.0009357224,0.0005104994],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.0887759,0.007487143,0.6996806,0.00008692826,0.00149195,0.03212379,0.0004790015,0.00009416737,0.0005579676,0.00007075779,0.008247043,0.1609048],"study_design_scores_gemma":[0.4760377,0.02924611,0.4214306,0.0008346979,0.0003962942,0.004106386,0.0005659471,0.001788496,0.0006816775,0.0003755119,0.06410074,0.0004358894],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9833967,0.0001428916,0.00001252307,0.00791386,0.001257329,0.0005885376,0.00001918907,0.00002074594,0.006648228],"genre_scores_gemma":[0.9899828,0.0001347431,0.005975953,0.002479236,0.0005366821,0.000004743388,0.00002580521,0.00003921998,0.0008208579],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3872618,"threshold_uncertainty_score":0.9999202,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07737395609271454,"score_gpt":0.4418125535232706,"score_spread":0.3644385974305561,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}